Two distinct trajectories of FEV1 in Adult Pulmonary Langerhans Cell Histiocytosis
A. Benattia (Paris (Île-de-France), France), R. Porcher (Paris (Île-de-France), France), E. Bugnet (Paris (Île-de-France), France), C. De Margerie-Mellon (Paris (Île-de-France), France), G. Lorillon (Paris (Île-de-France), France), A. Tazi (Paris (Île-de-France), France)
Source: International Congress 2022 – Relevant news in rare interstitial lung diseases
Session: Relevant news in rare interstitial lung diseases
Session type: Oral Presentation
Number: 4439
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Benattia (Paris (Île-de-France), France), R. Porcher (Paris (Île-de-France), France), E. Bugnet (Paris (Île-de-France), France), C. De Margerie-Mellon (Paris (Île-de-France), France), G. Lorillon (Paris (Île-de-France), France), A. Tazi (Paris (Île-de-France), France). Two distinct trajectories of FEV1 in Adult Pulmonary Langerhans Cell Histiocytosis. 4439
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|